Results 11 to 20 of about 103,375 (340)

A Review on Aspergillosis in Turkey: As a Main Fungal Disease in Poultry. [PDF]

Vet Med Sci
ABSTRACT Background Aspergillosis, a fungal disease caused by various species of the genus Aspergillus, poses a significant threat to the health and productivity of turkeys. Objective The current review aims to synthesize current knowledge regarding the aetiology, pathogenesis, clinical manifestations, diagnostic methods and management strategies ...
Alhassani ANA, Ahmed AT, Sanghvi G, Ganesan S, Al-Hetty HRAK, Sapaev IB, Singh A, Sudan P, Mustafa YF, Gholami-Ahangaran M.   +9 more
europepmc   +2 more sources

Chronic Pulmonary Aspergillosis Secondary Infection: A Case Report of <i>Achromobacter</i> spp. Lung Infection. [PDF]

Clin Case Rep
ABSTRACT Both pulmonary tuberculosis (PTB) and coronavirus disease‐2019 (COVID‐19) are risk factors for chronic pulmonary aspergillosis (CPA) and other pulmonary infectious diseases because of residual lung damage. We report a case of Achromobacter spp. infection following CPA in an immunocompetent woman with a history of PTB and COVID‐19.
Kuate MPN, Bongomin F, Denning DW.
europepmc   +2 more sources

COVID-19–Associated Pulmonary Aspergillosis, March–August 2020

Emerging Infectious Diseases, 2021
Pneumonia caused by severe acute respiratory syndrome coronavirus 2 emerged in China at the end of 2019. Because of the severe immunomodulation and lymphocyte depletion caused by this virus and the subsequent administration of drugs directed at the ...
J. Salmanton-García, Rosanne Sprute, J. Stemler, M. Bartoletti, D. Dupont, M. Valerio, C. García-Vidal, I. Falces-Romero, M. Machado, S. de la Villa, M. Schroeder, I. Hoyo, F. Hanses, K. Ferreira-Paim, D. Giacobbe, J. Meis, J. Gangneux, A. Rodríguez-Guardado, S. Antinori, E. Sal, Xhorxha Malaj, D. Seidel, O. Cornely, P. Koehler   +23 more
semanticscholar   +1 more source

Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients: a prospective study

Clinical Infectious Diseases, 2020
Background In this study we evaluated the incidence of invasive pulmonary aspergillosis among intubated patients with critical coronavirus disease 2019 (COVID-19) and evaluated different case definitions of invasive aspergillosis.
M. Bartoletti, R. Pascale, M. Cricca, M. Rinaldi, Angelo Maccaro, L. Bussini, Giacomo Fornaro, T. Tonetti, G. Pizzilli, Eugenia Francalanci, L. Giuntoli, A. Rubin, A. Moroni, S. Ambretti, F. Trapani, O. Vatamanu, V. Ranieri, A. Castelli, M. Baiocchi, R. Lewis, M. Giannella, P. Viale, Luigi Raumer, L. Guerra, F. Tumietto, A. Cascavilla, E. Zamparini, G. Verucchi, Simona Coladonato, Stefano Ianniruberto, L. Attard, Marina Tadolini Francesca Volpato, Giulio Virgili, N. Rossi, E. R. Del Turco, Viola Guardigni, G. Fasulo, N. Dentale, C. Fulgaro, G. Legnani, Emanuele Campaci, C. Basso, A. Zuppiroli, A. S. Passino, Giulia Tesini, L. Angelelli, Adriana Badeanu, A. Rossi, Giulia Santangelo, Flovia Dauti, Vidak Koprivika, Nicholas Roncagli, Ioannis Tzimas, G. Liuzzi, Irid Baxhaku, L. Pasinelli, M. Neri, Tommaso Zanaboni, Francesco Dell’Omo, A. Gori, Idina Zavatta, S. Antonini, Chiara Pironi, E. Piccini, L. Esposito, A. Zuccotti, G. Urbinati, A. Pratelli, A. Sarti, M. Semprini, E. Evangelisti, M. D'onofrio, G. Sasdelli   +72 more
semanticscholar   +1 more source

Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion

Intensive Care Medicine, 2020
Purpose Invasive pulmonary aspergillosis is increasingly reported in patients with influenza admitted to the intensive care unit (ICU). Classification of patients with influenza-associated pulmonary aspergillosis (IAPA) using the current definitions for ...
P. Verweij, B. Rijnders, R. Brüggemann, É. Azoulay, M. Bassetti, S. Blot, S. Blot, T. Calandra, C. Clancy, O. Cornely, T. Chiller, P. Depuydt, D. Giacobbe, N. Janssen, B. Kullberg, K. Lagrou, C. Lass‐Flörl, R. Lewis, P. Liu, O. Lortholary, O. Lortholary, J. Maertens, I. Martín-Loeches, M. Nguyen, T. Patterson, T. Rogers, J. Schouten, I. Spriet, L. Vanderbeke, J. Wauters, F. Veerdonk   +30 more
semanticscholar   +1 more source

Pulmonary aspergillosis: diagnosis and treatment

European Respiratory Review, 2022
Aspergillus species are the most frequent cause of fungal infections of the lungs with a broad spectrum of clinical presentations including invasive pulmonary aspergillosis (IPA) and chronic pulmonary aspergillosis (CPA).
F. Lamoth, T. Calandra
semanticscholar   +1 more source

COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment

Journal of Fungi, 2020
Like severe influenza, coronavirus disease-19 (COVID-19) resulting in acute respiratory distress syndrome (ARDS) has emerged as an important disease that predisposes patients to secondary pulmonary aspergillosis, with 35 cases of COVID-19 associated ...
A. Arastehfar, A. Carvalho, F. L. van de Veerdonk, J. Jenks, P. Koehler, R. Krause, O. Cornely, David S Perlin, C. Lass‐Flörl, M. Hoenigl   +9 more
semanticscholar   +1 more source

Evaluating the Potential of Galactosaminogalactan as a Diagnostic Target for Invasive Aspergillosis. [PDF]

Mycoses
ABSTRACT Background Early diagnosis of invasive aspergillosis (IA) is critical for the initiation of effective antifungal therapy. Currently, detection of galactomannan (GM), a secreted fungal glycan, is the most used culture‐independent diagnostic test for IA. However, limitations in the sensitivity and specificity of this test have led to interest in
Takazono T, Machida K, Le Mauff F, Sheppard DC, Koga S, Namie H, Hishigaki H, Amata J, Ito Y, Nakada N, Hirayama T, Yoshida M, Takeda K, Iwanaga N, Ide S, Tashiro M, Hosogaya N, Sakamoto N, Matsumoto K, Yanagihara K, Miyazaki Y, Izumikawa K, Mukae H.   +22 more
europepmc   +2 more sources

Late-Onset Invasive Aspergillosis With Pituitary Involvement and Dysfunction Following CD19 Chimeric Antigen Receptor T-Cell Therapy. [PDF]

EJHaem
ABSTRACT Introduction Invasive fungal infection (IFI) after chimeric antigen receptor (CAR) T‐cell therapy is less common than bacterial and viral infections, but can be fatal once it develops. As most cases occur within 30 days after CAR T‐cell infusion, late‐onset IFI—particularly mould infection—appears to be under‐recognised.
Ikeda D, Nawada T, Kondo T, Shinohara T, Nagano T, Kubota S, Hiyama R, Ueno M, Kobayashi H, Seike K, Fujiwara H, Asada N, Ennishi D, Fujii K, Fujii N, Makita M, Maeda Y.   +16 more
europepmc   +2 more sources

Multinational Observational Cohort Study of COVID-19–Associated Pulmonary Aspergillosis

Emerging Infectious Diseases, 2021
We performed an observational study to investigate intensive care unit incidence, risk factors, and outcomes of coronavirus disease–associated pulmonary aspergillosis (CAPA). We found 10%–15% CAPA incidence among 823 patients in 2 cohorts.
N. Janssen, R. Nyga, L. Vanderbeke, Cato Jacobs, M. Ergün, Jochem B. Buil, K. van Dijk, J. Altenburg, C. Bouman, Hans J. I. van der Spoel, B. Rijnders, A. Dunbar, J. Schouten, K. Lagrou, M. Bourgeois, M. Reynders, N. Van Regenmortel, L. Rutsaert, Piet Lormans, S. Feys, Yves Debavaye, F. Tamion, D. Costa, J. Maizel, H. Dupont, T. Chouaki, S. Nseir, B. Sendid, R. Brüggemann, F. L. van de Veerdonk, J. Wauters, P. Verweij   +31 more
semanticscholar   +1 more source